Navigation Links
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Date:8/22/2007

- Revised Trial Examines Single, Higher, More Concentrated Dose of

Alfimeprase -

SAN CARLOS, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO) today announced enrollment of the first patient in the SONOMA-3 (Speedy Opening of Non-functional and Occluded catheters with Mini-dose Alfimeprase-3) trial evaluating lead product candidate, alfimeprase, for the treatment of central venous catheter occlusion (CO).

This open-label, single-arm trial will evaluate the safety and efficacy of a single 10 milligram dose of alfimeprase with a concentration of 5 milligrams per milliliter in up to 100 patients with occluded central venous catheters.

Data from a previous Phase 3 trial in the CO program, SONOMA-2, showed that alfimeprase restored catheter function in patients with occluded catheters within 15 minutes with a p-value of 0.022. It did not however, meet the more stringent p-value required for a single pivotal trial, less than 0.00125.

"Analysis of data from our previous Phase 3 SONOMA study provided further evidence that alfimeprase is an active thrombolytic which has the potential to dissolve clots quickly and rapidly restore catheter function, however, the dose and concentration we used did not generate results in line with the target product profile we believe necessary for commercial success in this market," said Michael Levy, M.D., executive vice president of research and development for Nuvelo. "Preclinical experiments have provided evidence that increasing the concentration can result in marked improvement in thrombolytic activity. Accordingly, we are resuming development of alfimeprase in CO to evaluate the potential of a single, higher, m
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
3. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
4. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
5. Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
6. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
(Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
(Date:8/27/2015)... CUPERTINO, Calif. , Aug. 27, 2015 ... management is scheduled to present at three upcoming healthcare ... , President and CEO, will present at the Rodman ... 10:00 a.m. Eastern time. The conference is being held ... York City . A live audio webcast of ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3DURECT to Participate in Upcoming Healthcare Conferences 2
... SAN DIEGO, April 7, 2008 A ... shows that a proprietary blend,extracted from canola, Dermytol(TM), ... Dermytol(TM), a proprietary compound,developed by KGK Synergize Inc., ... protect skin cells from damage that may lead ...
... Research Meeting, DURHAM, N.C., April 7, 2008 ... dedicated to,treating diseases resulting from the failure of ... a Phase I clinical,safety study of a novel ... dry mouth associated with primary Sjogren,s syndrome. The,preliminary ...
Cached Medicine Technology:New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 3
(Date:8/28/2015)... ... August 28, 2015 , ... Santa Rosa was recently recognized, for the fourth ... Healthcare. In the KLAS “2015 Midterm Performance Review: Software & Services”, Santa Rosa achieved ... from Modern Healthcare and KLAS are directly related to our company culture.” said Richard ...
(Date:8/27/2015)... ... August 28, 2015 , ... ... out of foster care through “The Language of Flowers,” has joined the Youth ... work, particularly the organization’s YVLifeSet program, was piqued by her passion for helping ...
(Date:8/27/2015)... ... 2015 , ... According to an article published August 21st on ... the success of a patient who is attempting to lose weight. Specifically, the trial ... over that period, and compared those results with how helpful each patient felt their ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow ... quantitative PCR (qPCR) in the last decade. New features such as ... costs. On the flipside, where do lab managers, technicians, and researchers find handy ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Thriveology Founders, Dr. ... featured speakers at The Amazing Aging Expo in Denver, Colorado on Saturday, August 29, ... are consistently featured in media outlets as health authorities, and will present a two ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 3Health News:Article on Physician Influence on Weight Loss Highlights the Importance of a Doctor Who Cares, says Dr. Feiz & Associates 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2
... SIMI VALLEY, Calif., Oct. 10 Dr. ... maintained that techniques,exist to naturally reduce dependence on ... study published in the Journal of,Human Hypertension has ... chiropractic adjustments to correct,misalignment of the atlas vertebrae ...
... Movement, Takes on New ... Role at Dept. of State, ... Brinker, founder of Susan G. Komen for,the Cure, the world,s largest ... U.S. Department of State. Mrs. Laura Bush,was in attendance for the ...
... visit a worksite in your,community, contact Tim ... tkral@oregonrehabilitation.org , 503-585-3337. For,current photos, contact ... The Oregon Rehabilitation Association (ORA), http://www.oregonrehabilitation.org, ... with disabilities this October with National Disability,Employment ...
... Inc (OTC,Bulletin Board: NNTN) announced today that it,s ... record unaudited sales of $4,439,000 (CDN) and $601,000 ... July, August, and September 2007. Tim,Connolly, CEO of ... record,results for our first full quarter for InterACTIVE ...
... Succeed Antoine, CINCINNATI, Oct. 10, 2007 ... that Richard L. Antoine, global human resources,officer, will ... 39 years of,service. (Photo: http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-a ... http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-b ) In ...
... Yum! Brands Launches Global Campaign to Raise Awareness of ... WASHINGTON, Oct. 10 Friends of the World,Food ... World Hunger,Relief Week, a global consumer campaign that will ... Relief Week is spearheaded,by Yum! Brands, the world,s largest ...
Cached Medicine News:Health News:Lower Blood Pressure Without Drugs 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 3Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 4Health News:Revision: October is National Disability Employment Awareness Month 2Health News:Natural Nutrition Subsidiary Reports Record Third Quarter Revenue and EBITDA 2Health News:Richard L. Antoine to Retire as P&G's Global HR Officer 2Health News:Friends of WFP Welcomes 'World Hunger Relief Week' 2
... Used for temporary internal ... to the bladder. The filiform ... placement. Supplied sterile in peel-open ... CAUTION: Periodic evaluation is advised; ...
The horizontal needle box stores loaded needles according to the implant dosimetry plan. The ergonomic and lightweight design reduces time in the operating room....
The vertical needle holder conveniently positions 20 needles vertically in numbered positions for easy loading....
The Brachytherapy C-arm table is a versatile, adjustable table featuring hand and foot controls, removable sections, an X-ray film tray and grid, accessory rails and standard rail mount knee crutches...
Medicine Products: